https://www.selleckchem.com/pr....oducts/bevacizumab.h
Four studies had a low bias risk and one study had a high bias risk. Summary EC HR for the highest vs. lowest score of adherence to cancer prevention guidelines was 0.54 (95% CI, 0.40 to 0.73) and had a high heterogeneity (I2=86.1%). For the dose-response analysis, an increment of 1 significantly reduced the risk of EC by 6%. No significant publication bias was detected. This study suggested that adherence to cancer prevention guidelines was negatively related to EC risk. This study suggested that adherence to cancer prevention guide
Beğen
Yorum Yap
Paylaş
